OP-076 The Effect of Factor XIII Gene Polymorphism on qrs Duration in Patients with St Elevation Myocardial Infarction Treated with Fibrinolytic Therapy
Objectives Factor XIII is a important key regulator of fibrinolysis and haemostasis. Factor XIII Valine34Leucine (Val34Leu) gene polymorphism has been associated with accelerated fibrin stabilization and increasing resistance to fibrinolysis….